Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
Investment Firms›
Nolan Capital
AddedFeb 13, 2024
UpdatedJun 28, 2026
Nolan Capital

Nolan Capital

Operating

Nolan Capital, Inc.: A leading U.S. real estate and investment firm focusing on long-term growth since 2014.

Location
Hermosa Beach, CA, US
Founded
2014
Firm
Compare
Portfolio
Employees
Website

Nolan Capital, founded in 2014, is a family office investment firm focused on long-term growth opportunities in the United States. The company targets control equity investments in industry-leading U.S. companies with proven management teams. Nolan Capital's investment strategy spans various sectors, with a particular interest in growth-oriented businesses.

The firm's portfolio includes notable companies in the biotechnology and gene therapy sectors, such as Encoded Therapeutics, Jaguar Gene Therapy, Palvella Therapeutics, and Taysha Gene Therapies. Nolan Capital participates in various investment rounds, from seed to Series D, demonstrating its commitment to supporting companies at different stages of growth. Founded by Peter Nolan, the firm leverages its expertise to identify and nurture promising investment opportunities.

Nolan Capital - Portfolio Snapshot

Portfolio activity breakdown across disclosed investments and stages

Total Investments6
Current Portfolio Count3
Total Portfolio Exits1

Top Investment Stages

Series B2 (33.3%)
Series D2 (33.3%)
Seed1 (16.7%)
Series C1 (16.7%)

Stage Mix

Series B 33%Series D 33%Seed 17%Series C 17%

Concentration shown as share of disclosed investments by stage.

Recent Investments

Palvella Therapeutics logo

Palvella Therapeutics

Jaguar Gene Therapy logo

Jaguar Gene Therapy

Taysha Gene Therapies logo

Taysha Gene Therapies

Encoded Therapeutics logo

Encoded Therapeutics

Nolan Capital - Similar Investment Firms

Beverly Capital logo

Beverly Capital

beverlycap.com

Nala Investments logo

Nala Investments

Nalu Capital logo

Nalu Capital

nalu.fund

NLM Capital Partners logo

NLM Capital Partners

nlmcapital.com

McNally Capital logo

McNally Capital

mcnallycapital.com

Nant Capital logo

Nant Capital

nantworks.com

Nellore Capital logo

Nellore Capital

North Haven Capital logo

North Haven Capital

NGN Capital logo

NGN Capital

ngncapital.com

Navy Capital logo

Navy Capital

navycapital.com

New Capital Partners logo

New Capital Partners

NMT Capital logo

NMT Capital

nmtcapital.com

NewVale Capital logo

NewVale Capital

newvalecapital.com

Northstar Capital logo

Northstar Capital

Denali Growth Partners logo

Denali Growth Partners

denaligrowth.com

Nolan Capital - Classification

Also Known As
  • Nolan Capital PTY Limited
NAICS
  • 520000Finance and Insurance
  • 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
  • 523900Other Financial Investment Activities
  • 523990All Other Financial Investment Activities
  • 523999Miscellaneous Financial Investment Activities
SIC
  • 6700Holding And Other Investment Offices
  • 6790Miscellaneous Investing
  • 6799Investors, Not Elsewhere Classified
Show 6 more industry codes
NAICS
  • 525000Funds, Trusts, and Other Financial Vehicles
  • 523910Miscellaneous Intermediation
  • 523940Portfolio Management and Investment Advice
SIC
  • 6000Depository Institutions
  • 6720Investment Offices
  • 6722Management Investment Offices, Open-end